Advisory Resource Group Sells 7,010 Shares of Aflac Incorporated (NYSE:AFL)

Advisory Resource Group decreased its holdings in shares of Aflac Incorporated (NYSE:AFL) by 14.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 42,698 shares of the financial services provider’s stock after selling 7,010 shares during the period. Aflac comprises 1.0% of Advisory Resource Group’s portfolio, making the stock its 29th biggest holding. Advisory Resource Group’s holdings in Aflac were worth $4,774,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in AFL. McIlrath & Eck LLC raised its position in Aflac by 29.3% in the 3rd quarter. McIlrath & Eck LLC now owns 2,490 shares of the financial services provider’s stock worth $278,000 after purchasing an additional 564 shares during the last quarter. Unigestion Holding SA grew its position in shares of Aflac by 13.1% during the 3rd quarter. Unigestion Holding SA now owns 54,074 shares of the financial services provider’s stock worth $6,045,000 after buying an additional 6,282 shares during the period. Toronto Dominion Bank boosted its stake in Aflac by 75.9% in the third quarter. Toronto Dominion Bank now owns 269,573 shares of the financial services provider’s stock valued at $30,138,000 after acquiring an additional 116,341 shares during the last quarter. Coldstream Capital Management Inc. grew its holdings in Aflac by 0.3% during the 3rd quarter. Coldstream Capital Management Inc. now owns 62,936 shares of the financial services provider’s stock worth $7,035,000 after acquiring an additional 171 shares during the period. Finally, Brophy Wealth Management LLC acquired a new position in shares of Aflac in the 3rd quarter valued at $590,000. 67.44% of the stock is owned by institutional investors and hedge funds.

Aflac Trading Down 0.7 %

AFL stock opened at $104.22 on Wednesday. The stock has a market cap of $57.90 billion, a price-to-earnings ratio of 15.70, a price-to-earnings-growth ratio of 2.16 and a beta of 0.97. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.08. The company has a fifty day moving average price of $110.91 and a two-hundred day moving average price of $102.47. Aflac Incorporated has a one year low of $75.07 and a one year high of $115.50.

Aflac (NYSE:AFL) last released its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.69 by $0.47. The business had revenue of $2.95 billion during the quarter, compared to analysts’ expectations of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The firm’s quarterly revenue was down 40.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.84 EPS. Equities analysts anticipate that Aflac Incorporated will post 7.27 EPS for the current year.

Aflac Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Wednesday, February 19th will be issued a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date of this dividend is Wednesday, February 19th. This is a boost from Aflac’s previous quarterly dividend of $0.50. Aflac’s dividend payout ratio is presently 30.12%.

Analyst Upgrades and Downgrades

AFL has been the topic of several research analyst reports. UBS Group raised their price objective on Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 14th. JPMorgan Chase & Co. boosted their price objective on Aflac from $85.00 to $90.00 and gave the company a “neutral” rating in a research report on Thursday, October 3rd. Morgan Stanley raised their target price on shares of Aflac from $91.00 to $98.00 and gave the stock an “equal weight” rating in a report on Monday, August 19th. Bank of America upped their target price on shares of Aflac from $115.00 to $124.00 and gave the stock a “buy” rating in a research note on Thursday, October 10th. Finally, Truist Financial upped their price objective on Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $98.73.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.